SAN DIEGO (AP) _ Imprimis Pharmaceuticals Inc. (IMMY) on Tuesday reported a loss of $5.7 million in its third quarter.
The San Diego-based company said it had a loss of 28 cents per share.
The pharmaceutical and drug compounding company posted revenue of $6.5 million in the period.
The company's shares closed at $1.66. A year ago, they were trading at $2.40.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMMY at https://www.zacks.com/ap/IMMY